Association of Research and Development Investments With Treatment Costs for New Drugs Approved From 2009 to 2018

IMPORTANCE: Drug companies frequently claim that high prices are needed to recoup spending on research and development. If high research and development costs justified high drug prices, then an association between these 2 measures would be expected. OBJECTIVE: To examine the association between tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wouters, Olivier J., Berenbrok, Lucas A., He, Meiqi, Li, Yihan, Hernandez, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513642/
https://www.ncbi.nlm.nih.gov/pubmed/36156148
http://dx.doi.org/10.1001/jamanetworkopen.2022.18623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513642/
https://www.ncbi.nlm.nih.gov/pubmed/36156148
http://dx.doi.org/10.1001/jamanetworkopen.2022.18623

Ejemplares similares